IBD new medication studies

Information about current studies recruiting patients:

Principal investigator:  

Atilla Ertan, MD

Currently recruiting for Crohn's Disease, Ulcerative Colitis, and IBS Patients for Clinical Trials.   For more infomration, contact Clinical Research Coordinators:

Inci E. Ertan, PhD or Dora L. Hawkinson, PA-C

713-500-6457 ph     713-704-3485 fx

Dora.L.Hawkinson@uth.tmc.edu

Location:

64000 Fannin Street, Suite 1400; Houston, Texas 77030 United States

Abbott                                                    Active

A 5-Year, National Registry Study of Humira® (Adalimumab) in Patients with Moderately to Severely Active Crohn's Disease (CD)”

Barrx Protocol                                      Active

“HALO  Patient National Registry: Ablation of Barrett's Esophagus”

UCB Protocol                                                 Active

 “SECURE”: A Non-Interventional Long-term Post-Marketing Registry of Patients Treated with Certolizumab Pegol (Cimzia®) for Crohn's Disease”

Centocor Protocol                                 Active

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Subjects with Moderately to Severely Active Crohn’s Disease”

Centocor Protocol                                 Active

“A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Subjects with Moderately to Severely Active Crohn’s Disease”.

How to Volunteer for a Clinical Trial